JP2023522029A5 - - Google Patents

Info

Publication number
JP2023522029A5
JP2023522029A5 JP2022562645A JP2022562645A JP2023522029A5 JP 2023522029 A5 JP2023522029 A5 JP 2023522029A5 JP 2022562645 A JP2022562645 A JP 2022562645A JP 2022562645 A JP2022562645 A JP 2022562645A JP 2023522029 A5 JP2023522029 A5 JP 2023522029A5
Authority
JP
Japan
Prior art keywords
igg
molecule
modified
modified igg
canid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022562645A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023522029A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/027836 external-priority patent/WO2021212081A1/en
Publication of JP2023522029A publication Critical patent/JP2023522029A/ja
Publication of JP2023522029A5 publication Critical patent/JP2023522029A5/ja
Pending legal-status Critical Current

Links

JP2022562645A 2020-04-17 2021-04-16 イヌ科動物抗体バリアント Pending JP2023522029A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063011453P 2020-04-17 2020-04-17
US63/011,453 2020-04-17
PCT/US2021/027836 WO2021212081A1 (en) 2020-04-17 2021-04-16 Canine antibody variants

Publications (2)

Publication Number Publication Date
JP2023522029A JP2023522029A (ja) 2023-05-26
JP2023522029A5 true JP2023522029A5 (https=) 2024-04-19

Family

ID=75888187

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022562645A Pending JP2023522029A (ja) 2020-04-17 2021-04-16 イヌ科動物抗体バリアント

Country Status (17)

Country Link
US (1) US20230242635A1 (https=)
EP (1) EP4136106A1 (https=)
JP (1) JP2023522029A (https=)
KR (1) KR20230005156A (https=)
CN (1) CN115996949A (https=)
AU (1) AU2021256056A1 (https=)
BR (1) BR112022020944A2 (https=)
CA (1) CA3175921A1 (https=)
CL (2) CL2022002857A1 (https=)
CO (1) CO2022014695A2 (https=)
EC (1) ECSP22080846A (https=)
IL (1) IL297287A (https=)
MX (1) MX2022012866A (https=)
PE (1) PE20230108A1 (https=)
PH (1) PH12022552742A1 (https=)
TW (1) TW202204403A (https=)
WO (1) WO2021212081A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10093731B2 (en) 2017-02-24 2018-10-09 Kindred Biosciences, Inc. Anti-IL31 antibodies for veterinary use
US12297272B2 (en) 2017-08-15 2025-05-13 Eianco US inc. IgG Fc variants for veterinary use
CN113544153B (zh) 2019-01-03 2024-12-10 因外泰克斯公司 用于增加治疗剂在犬中的半衰期的组合物及使用方法
CN120590527A (zh) 2020-05-11 2025-09-05 因外泰克斯公司 用于增加治疗剂在犬中的半衰期的组合物和使用方法
KR20230038522A (ko) 2020-07-10 2023-03-20 인베티엑스 인코포레이티드 고양이에서 치료제의 반감기를 증가시키기 위한 조성물 및 사용 방법
MX2023003624A (es) 2020-09-28 2023-04-11 Zoetis Services Llc Variantes de anticuerpos caninos.
AU2023289332A1 (en) * 2022-06-21 2024-12-12 Zoetis Services Llc Canine antibody mutants
JP2026508096A (ja) 2023-01-20 2026-03-10 ゾエティス・サービシーズ・ユーケー・リミテッド 治療抗体
WO2025166165A1 (en) * 2024-02-01 2025-08-07 Zoetis Services, Llc Compositions and methods for modifying antibody effector functions

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US6284471B1 (en) 1991-03-18 2001-09-04 New York University Medical Center Anti-TNFa antibodies and assays employing anti-TNFa antibodies
US5698762A (en) 1994-12-09 1997-12-16 Dauerman; Leonard Microwave-assisted pyrolysis of waste polyaromatic hydrocarbons
US20030031671A1 (en) 2001-08-01 2003-02-13 Sydney Welt Methods of treating colon cancer utilizing tumor-specific antibodies
AU2005285347A1 (en) 2004-08-19 2006-03-23 Genentech, Inc. Polypeptide variants with altered effector function
AU2005304624B2 (en) 2004-11-12 2010-10-07 Xencor, Inc. Fc variants with altered binding to FcRn
US8546543B2 (en) 2004-11-12 2013-10-01 Xencor, Inc. Fc variants that extend antibody half-life
US8367805B2 (en) 2004-11-12 2013-02-05 Xencor, Inc. Fc variants with altered binding to FcRn
WO2012024650A2 (en) 2010-08-19 2012-02-23 Abbott Laboratories Anti-ngf antibodies and their use
PL2670432T3 (pl) * 2011-02-04 2021-10-11 Zoetis Services Llc Kompozycje immunogenne Bordetella bronchiseptica
US8790651B2 (en) 2011-07-21 2014-07-29 Zoetis Llc Interleukin-31 monoclonal antibody
CA2875783C (en) 2012-06-06 2018-12-11 Zoetis Llc Caninized anti-ngf antibodies and methods thereof
KR102605798B1 (ko) * 2015-02-05 2023-11-23 추가이 세이야쿠 가부시키가이샤 이온 농도 의존적 항원 결합 도메인을 포함하는 항체, Fc 영역 개변체, IL-8에 결합하는 항체, 및 그들의 사용
UA120981C2 (uk) * 2015-09-18 2020-03-10 Чугаі Сейяку Кабусікі Кайся Антитіло, що зв'язується з il-8, та його застосування
EP3448427A1 (en) * 2016-04-29 2019-03-06 CureVac AG Rna encoding an antibody
EP3494991A4 (en) * 2016-08-05 2020-07-29 Chugai Seiyaku Kabushiki Kaisha COMPOSITION FOR THE PROPHYLAXIS OR TREATMENT OF IL-8 RELATED DISEASES
US20200181258A1 (en) * 2016-10-17 2020-06-11 Vetoquinol Sa Modified antibody constant region
US10093731B2 (en) * 2017-02-24 2018-10-09 Kindred Biosciences, Inc. Anti-IL31 antibodies for veterinary use
US20210388053A1 (en) * 2018-10-18 2021-12-16 Kindred Biosciences, Inc. Fc Variants with Altered Binding to Neonatal Fc Receptor (FCRN) for Veterinary Use
CN113544153B (zh) * 2019-01-03 2024-12-10 因外泰克斯公司 用于增加治疗剂在犬中的半衰期的组合物及使用方法
US20220169740A1 (en) * 2019-03-20 2022-06-02 Kindred Biosciences, Inc. NGF Antagonists for Medical Use
MX2023003624A (es) * 2020-09-28 2023-04-11 Zoetis Services Llc Variantes de anticuerpos caninos.
EP4284825A2 (en) * 2021-01-28 2023-12-06 Zoetis Services LLC Mutations in canine antibody constant regions

Similar Documents

Publication Publication Date Title
JP2023522029A5 (https=)
JP2023522030A5 (https=)
JP2023543262A5 (https=)
JP2024026255A5 (https=)
CN110382529B (zh) 工程化的异源二聚体蛋白质
EP2170960B1 (en) Single-domain antigen-binding proteins that bind mammalian igg
JP6490038B2 (ja) 交差結合領域の配向性を有する二重可変領域抗体様結合タンパク質
US9284347B2 (en) Chromatographic method for purifying FC-containing proteins
JP7189142B2 (ja) 抗ヒトアネキシンa1抗体
WO2020076853A1 (en) Trispecific anti-cd38, anti-cd28, and anti-cd3 binding proteins and methods of use for treating viral infection
US20110027294A1 (en) Anti-Respiratory Syncytial Virus Antibodies, Antigens and Uses Thereof
WO2021047559A1 (zh) 一种断裂型内含肽、使用其的重组多肽的制备方法
JP2021511830A5 (https=)
CN104428317A (zh) 修饰的抗体区及其用途
CN113660944A (zh) 用于补体相关疾病的融合蛋白构建体
WO2023186120A1 (zh) 抗血清白蛋白纳米抗体及其衍生物
JP2023551194A5 (https=)
CN1259972C (zh) 抗凝剂和人源化抗冯·维勒布兰德氏因子的单克隆抗体
KR20200004292A (ko) 항 인터페론 감마 항체 및 그의 용도
JP2024505072A5 (https=)
JP2024503212A (ja) ネコ科動物抗体の定常領域における変異
JP2024501771A5 (https=)
JP2023542737A5 (https=)
CN114786720A (zh) TriAx抗体的组合物及其制备和使用方法
JP2024500354A (ja) ヘテロ二量体化のための直交変異